Third, the optimal positioning and sequencing of GLP-1-based therapies relative to resmetirom and other emerging MASH agents (e.g., lanifibranor, pegozafermin, semaglutide combination regimens) requires dedicated combination trials, of which preliminary data from the MAESTRO-NASH secondary analysis are encouraging
Seek emergency medical care if you experience systemic symptoms or if the rash worsens
Key mechanisms through which weight loss may influence menstruation include: Hormonal rebalancing: Rapid weight loss can temporarily alter the balance of reproductive hormones, including oestrogen, progesterone, luteinising hormone (LH), and follicle-stimulating hormone (FSH)
Exploring the weight loss benefits, side effects, and cost What does not losing weight on Zepbound actually mean
(2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Injection site reactions on tirzepatide Injection site reactions redness, swelling, itching, or a small bruise at the site occurred in 3.2% of Mounjaro users versus 0.4% of placebo participants in the SURPASS trials, per the prescribing information